{"id":"W4399394935","doi":"10.1200/jco.2024.42.16_suppl.tps5122","title":"Darolutamide plus androgen-deprivation therapy in patients with high-risk biochemical recurrence of prostate cancer: A phase 3, randomized, double-blind, placebo-controlled study (ARASTEP).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Placebo; Oncology; Internal medicine; Randomized controlled trial; Double blind; Cancer; Urology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001166127,0.001313424,0.001998194,0.0004703019,0.0002901788,0.000745213,0.0008792325,0.001304461,0.005976978],"category_scores_gemma":[0.0009065035,0.0004818717,0.001534346,0.0004104068,0.0008104209,0.000786699,0.0003043549,0.002155926,0.0008652634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004326921,"about_ca_system_score_gemma":0.001085179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007969555,"about_ca_topic_score_gemma":0.002376288,"domain_scores_codex":[0.9996943,0.0001601036,0.00001706261,0.00005148262,0.00002661369,0.00005045018],"domain_scores_gemma":[0.9994605,0.0001271115,0.0001327744,0.00003933164,0.00004031705,0.0002000035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9548299,0.01616598,0.0007059635,0.0009859743,0.0009774733,0.00005815577,0.00005741638,0.0002960805,0.005718345,0.00009456246,0.0007780173,0.01933202],"study_design_scores_gemma":[0.9209787,0.07621688,0.001527815,0.00002439317,0.000250351,0.00003214517,0.00001726985,0.0002247735,0.00029204,0.00005765673,0.0003679911,0.00001006084],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848932,0.005807642,0.0006956089,0.0004896099,0.000433929,0.004693684,0.001256137,0.000177371,0.001552726],"genre_scores_gemma":[0.9831151,0.004242504,0.001935196,0.001265242,0.0005061178,0.005008894,0.00127202,0.00002473445,0.002630146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005976978,"threshold_uncertainty_score":0.01999497,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0748434723450314,"score_gpt":0.4590299950455526,"score_spread":0.3841865227005212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}